Market Research Futures Added a Latest Report “Pleurisy Market” with Latest Advancement and covering all the Regions with Competitive Players. This Report is published in May 2018 with 90 pages, Full TOC, – Forecast to 2027.
Pleurisy Market Information: By Diagnosis Devices (Thoracentesis, Video-Assisted Thoracic Surgery, Blood Test), By Treatment (Antibiotics, Antifungals, Blood Thinners), By End User (Hospital, Clinics, Diagnostics Laboratories) – Global Forecast till 2023
The global pleurisy market is expected to grow at a CAGR of 6.2% during the forecast period 2017-2023.
KEY PLAYERS FOR PLEURISY MARKET
Scanlan International, Inc. (U.S.), Sontec Instruments (U.S.), Pilling Surgical Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Olympus Corporation (Japan), Delacroix-Chevalier (France), Myra & Co. (India), Wexler Surgical (Texas) and others.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1711 .
MARKET SCENARIO FOR PLEURISY MARKET
Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss.
Pneumonia, pulmonary embolism, autoimmune disorder, lung cancer, heart surgery, pancreatitis, chest trauma, and asbestosis are the diseases which cause pleurisy, thus, rising in population affected with these disease are the leading factor for the growth of global pleurisy market.
According to a report published by the World Cancer Research Fund International, in 2015, about 58% of lung cancer cases occurred in the developing countries. In a similar report by Centers for Disease Control and Prevention (CDC), in 2017, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States.
SEGMENTATIONS FOR PLEURISY MARKET
The global pleurisy market is segmented on the basis of diagnosis devices, treatment, and by end user.
On the basis of the diagnosis devices, it is segmented into thoracentesis, video-assisted thoracic surgery, imaging devices, blood test, and others. Furthermore, imaging devices are segmented as computed tomography, magnetic resonance imaging, ultrasound, and others.
On the basis of the treatment, it is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others.
On the basis of end user, it is segmented into hospital, clinics, diagnostics laboratories, and others.
REGIONAL ANALYSIS FOR PLEURISY MARKET
The Americas dominate the global pleurisy market owing to the rising prevalence of disease such as autoimmune disorders, lung cancer, heart surgery, pancreatitis, chest trauma. Furthermore increasing government support for research & development and high healthcare spending have fuelled the growth of the market in this region. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 215,951 people in the United States were diagnosed with lung cancer, including 113,326 men and 102,625 women. Also around 155,526 people in the United States died from lung cancer, including 84,859 men and 70,667 women.
Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.
Asia Pacific is the fastest growing pleurisy market owing to the high presence of patient with chronic disease. Although rapidly developing healthcare technology, increasing demand for new treatment methods in countries like India and China is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare provide the opportunity for the market players to fill the gap between demand and supply and maximize the profits.
SEGMENTATIONS FOR PLEURISY MARKET
The global pleurisy market is segmented on the basis of diagnosis devices, treatment, and by end user.
On the basis of the diagnosis devices, it is segmented into thoracentesis, video-assisted thoracic surgery, imaging devices, blood test, and others. Furthermore, imaging devices are segmented as computed tomography, magnetic resonance imaging, ultrasound, and others.
On the basis of the treatment, it is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others.
On the basis of end user, it is segmented into hospital, clinics, diagnostics laboratories, and others.
REGIONAL ANALYSIS FOR PLEURISY MARKET
The Americas dominate the global pleurisy market owing to the rising prevalence of disease such as autoimmune disorders, lung cancer, heart surgery, pancreatitis, chest trauma. Furthermore increasing government support for research & development and high healthcare spending have fuelled the growth of the market in this region. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 215,951 people in the United States were diagnosed with lung cancer, including 113,326 men and 102,625 women. Also around 155,526 people in the United States died from lung cancer, including 84,859 men and 70,667 women.
Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.
Read More @ https://www.marketresearchfuture.com/reports/pleurisy-market-1711
About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
